Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1561 AL 1575

The role of neurotransmitters in the development of Parkinson's disease-related psychosis

Factor SA, McDonald WM, Goldstein FC.

Eur J Neurol. 2017 Oct;24(10):1244-1254. doi: 10.1111/ene.13376. Epub 2017 Jul 31.

Perturbation During Treadmill Training Improves Dynamic Balance and Gait in Parkinson's Disease: A Single-Blind Randomized Controlled Pilot Trial

Steib S, Klamroth S, Gaßner H, Pasluosta C, Eskofier B, Winkler J, Klucken J, Pfeifer K.

Neurorehabil Neural Repair. 2017 Aug;31(8):758-768. doi: 10.1177/1545968317721976. Epub 2017 Jul 31.

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Alam Q, Alam MZ, Sait KHW, Anfinan N, Noorwali AW, Kamal MA, Khan MSA, Haque A.

Curr Drug Metab. 2017;18(9):868-876. doi: 10.2174/1389200218666170728115606.

Implications of PEGylation of Carbon Nanotubes for Central Nervous System Bioavailability

Bruch GE, Cordeiro MF, Gomides LS, Peixoto C, Cordeiro AP, Dal Bosco L, Santos AP, Barros DM.

CNS Neurol Disord Drug Targets. 2017;16(9):983-989. doi: 10.2174/1871527316666170731111735.

Brain Angiotensin II Involvement in Chronic Mental Disorders

Basmadjian OM, Occhieppo VB, Marchese NA, Baiardi G, Bregonzio C.

Protein Pept Lett. 2017 Nov 17;24(9):817-826. doi: 10.2174/0929866524666170728144801.

Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells

Calatayud C, Carola G, Consiglio A, Raya A.

Curr Opin Genet Dev. 2017 Oct;46:123-131. doi: 10.1016/j.gde.2017.06.002. Epub 2017 Jul 28.

The role of Th17 cells in auto-inflammatory neurological disorders

Tahmasebinia F, Pourgholaminejad A.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):408-416. doi: 10.1016/j.pnpbp.2017.07.023. Epub 2017 Jul 29.

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease

Segura-Aguilar J.

Neural Regen Res. 2017 Jun;12(6):897-901. doi: 10.4103/1673-5374.208560.

Deep Brain Stimulation in Parkinson's Disease: New and Emerging Targets for Refractory Motor and Nonmotor Symptoms

Anderson D, Beecher G, Ba F.

Parkinsons Dis. 2017;2017:5124328. doi: 10.1155/2017/5124328. Epub 2017 Jul 6.

Methylene blue and its analogues as antidepressant compounds

Delport A, Harvey BH, Petzer A, Petzer JP.

Metab Brain Dis. 2017 Oct;32(5):1357-1382. doi: 10.1007/s11011-017-0081-6. Epub 2017 Jul 31.

Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease

Wang Y, Yang Z, Le W.

Neurosci Bull. 2017 Oct;33(5):543-551. doi: 10.1007/s12264-017-0160-z. Epub 2017 Jul 31.

Experimental animal models of Parkinson's disease: A transition from assessing symptomatology to α-synuclein targeted disease modification

Ko WKD, Bezard E.

Exp Neurol. 2017 Dec;298(Pt B):172-179. doi: 10.1016/j.expneurol.2017.07.020. Epub 2017 Jul 29.

Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease

West AB.

Exp Neurol. 2017 Dec;298(Pt B):236-245. doi: 10.1016/j.expneurol.2017.07.019. Epub 2017 Jul 29.

A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism

Ringman JM, Casado M, Van Berlo V, Pa J, Joseph-Mathurin N, Fagan AM, Benzinger T, Bateman RJ, Morris JC.

Neurosci Lett. 2017 Sep 14;657:11-15. doi: 10.1016/j.neulet.2017.07.046. Epub 2017 Jul 29.

Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis

Atkinson-Clement C, Pinto S, Eusebio A, Coulon O.

Neuroimage Clin. 2017 Jul 15;16:98-110. doi: 10.1016/j.nicl.2017.07.011. eCollection 2017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias